
InspireMD NSPR
$ 1.14
-5.79%
Annual report 2025
added 03-18-2026
InspireMD Interest Expense 2011-2026 | NSPR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense InspireMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 200 K | -371 K | 119 K | 721 K | 1.04 M | 1.41 M | 4.27 M | 1.24 M | 730 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.27 M | -371 K | 1.04 M |
Quarterly Interest Expense InspireMD
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 119 K | 119 K | - | 197 K | 188 K | 179 K | - | 246 K | 275 K | 301 K | - | 361 K | 359 K | 352 K | - | 2.16 M | 884 K | 1.28 M | 1.12 M | 988 K | 2.11 M | 988 K | 10 K | 15 K | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.16 M | 10 K | 612 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 13.38 | 2.29 % | $ 1.81 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.28 | 1.86 % | $ 123 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.08 | -1.16 % | $ 314 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
78 K | $ 25.74 | -1.0 % | $ 218 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 90.74 | -3.16 % | $ 12.3 B | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.08 | -1.89 % | $ 1.26 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 5.16 | -5.84 % | $ 1.09 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.14 | -4.3 % | $ 355 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.55 | -2.68 % | $ 378 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.79 | -2.85 % | $ 1.14 B | ||
|
LivaNova PLC
LIVN
|
664 K | $ 61.29 | -3.34 % | $ 3.34 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 55.11 | 0.07 % | $ 1.62 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.35 | 2.69 % | $ 64 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 84.64 | -0.83 % | $ 2.94 B | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.23 | -4.3 % | $ 50 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 82.28 | -1.41 % | $ 48.1 B | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.4 | 1.8 % | $ 502 M | ||
|
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Myomo
MYO
|
-668 K | $ 0.82 | -1.19 % | $ 34.3 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Natus Medical Incorporated
NTUS
|
1.87 M | - | 1.94 % | $ 1.05 B | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 11.91 | -3.33 % | $ 472 M |